This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novotyr Therapeutics Ltd.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Avi Weissberg: Innovator in Protein Kinase Modulation
Introduction
Avi Weissberg is a notable inventor based in Rishon Lezion, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents targeting protein kinases. His work focuses on innovative solutions for treating various disorders, including cancer and psoriasis.
Latest Patents
Weissberg holds a patent for "Protein kinase modulators and therapeutic uses thereof." This invention introduces new tyrphostin derivatives that act as substrate competitive protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors. The patent outlines methods for their preparation, pharmaceutical compositions that include these compounds, and their applications as chemotherapeutic agents for preventing and treating PTK and RTK related disorders, such as metabolic, fibrotic, and cell proliferative disorders.
Career Highlights
Throughout his career, Weissberg has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to impact the treatment landscape for serious health conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Weissberg has collaborated with esteemed colleagues, including Alexander Levitzki and Hadas Reuveni. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.
Conclusion
Avi Weissberg is a prominent figure in the field of protein kinase modulation, with a focus on developing innovative treatments for serious health conditions. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient care.